Promising Phase II Data For Sanofi’s Hemlibra Rival Fitusiran

Gene Therapy Also Approaching Market

 
• By Andrew McConaghie
  
Sanofi_France
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip